Literature DB >> 11486684

Long-term results of the Boytchev procedure for the treatment of recurrent dislocation of the shoulder.

P Zamora-Navas1, A Borrás Verdera, J Porras García, A Padilla Márquez, P Linares.   

Abstract

The authors present the long-term results obtained with the Boytchev technique in the treatment of recurrent anterior dislocation of the shoulder. Recurrence, clinical outcome and functional limitations were evaluated. A total of 27 shoulders in 25 patients were studied. The average follow-up period was 13.3 years. There were no immediate neurovascular complications and no residual pain. The average recovery time was 4.3 months. Dislocation recurred in five shoulders (18%) and 18.5% of the patients were left with restricted mobility. All patients resumed their previous employment although sporting capacity recovered to pre-injury levels in only 9 of 15 patients. The results were classified as good in 18.5% and as excellent in 40.7% of the patients, but the remaining 40.7% had a fair or poor result. In conclusion, the recurrence rate is high and nearly 20% of the patients are left with limited shoulder mobility. Furthermore, although all the patients were able to return to their job, only 60% of those engaged in sports regained their previous level. This technique, although attractive, is better avoided.

Entities:  

Mesh:

Year:  2001        PMID: 11486684

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  2 in total

1.  Stabilizing effect of the transferred conjoined tendon on shoulder stability.

Authors:  Lei-Sheng Jiang; Yi-Min Cui; Zhi-De Zhou; Li-Yang Dai
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-12-23       Impact factor: 4.114

2.  Modified Boytchev procedure for treatment of recurrent anterior dislocation of shoulder.

Authors:  Anant Kumar Garg; Saankritya Ayan; Vikas Keshari; Debi Kundu; Kiran Kumar Mukhopadhyay; Biplab Acharyya
Journal:  Indian J Orthop       Date:  2011-07       Impact factor: 1.251

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.